BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Higuchi S, Kobayashi M, Yoshikawa Y, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. IL-4 mediates dicloxacillin-induced liver injury in mice. Toxicol Lett. 2011;200:139-145. [PMID: 21094227 DOI: 10.1016/j.toxlet.2010.11.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Zha H, Li Q, Chang K, Xia J, Li S, Tang R, Li L. Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two Bifidobacterium strains Pre-Treated Rats With D-Galactosamine-Induced Liver Injury. Front Immunol 2022;13:791152. [DOI: 10.3389/fimmu.2022.791152] [Reference Citation Analysis]
2 Watanabe K, Oda S, Matsubara A, Akai S, Yokoi T. Establishment and characterization of a mouse model of rhabdomyolysis by coadministration of statin and fibrate. Toxicology Letters 2019;307:49-58. [DOI: 10.1016/j.toxlet.2019.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gao B, Wang H, Lafdil F, Feng D. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol. 2012;57:430-441. [PMID: 22504331 DOI: 10.1016/j.jhep.2012.01.029] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 9.0] [Reference Citation Analysis]
4 Proctor WR, Chakraborty M, Fullerton AM, Korrapati MC, Ryan PM, Semple K, Morrison JC, Berkson JD, Chea LS, Yang Q, Li AP, Spolski R, West EE, Rochman Y, Leonard WJ, Bourdi M, Pohl LR. Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology 2014;60:1741-52. [PMID: 24723460 DOI: 10.1002/hep.27169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
5 Akai S, Uematsu Y, Tsuneyama K, Oda S, Yokoi T. Kupffer cell-mediated exacerbation of methimazole-induced acute liver injury in rats: Methimazole-induced liver injury in rats. J Appl Toxicol 2016;36:702-15. [DOI: 10.1002/jat.3202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
6 Fukui H. Cytokines in Hepatic Injury. Liver Pathophysiology. Elsevier; 2017. pp. 341-54. [DOI: 10.1016/b978-0-12-804274-8.00027-8] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Takai S, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism: Mechanism of amiodarone-induced liver injury. J Appl Toxicol 2016;36:35-47. [DOI: 10.1002/jat.3141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Endo S, Yano A, Fukami T, Nakajima M, Yokoi T. Involvement of miRNAs in the early phase of halothane-induced liver injury. Toxicology 2014;319:75-84. [PMID: 24598351 DOI: 10.1016/j.tox.2014.02.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
9 Matsuo K, Sasaki E, Higuchi S, Takai S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury. Toxicol Lett 2014;224:215-24. [PMID: 24184165 DOI: 10.1016/j.toxlet.2013.10.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
10 Yano A, Oda S, Fukami T, Nakajima M, Yokoi T. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury. Toxicol Lett. 2014;228:13-24. [PMID: 24747151 DOI: 10.1016/j.toxlet.2014.04.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
11 Yano A, Higuchi S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of immune-related factors in diclofenac-induced acute liver injury in mice. Toxicology. 2012;293:107-114. [PMID: 22285467 DOI: 10.1016/j.tox.2012.01.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
12 Jia R, Oda S, Tsuneyama K, Urano Y, Yokoi T. Establishment of a mouse model of troglitazone-induced liver injury and analysis of its hepatotoxic mechanism. J Appl Toxicol 2019;39:1541-56. [PMID: 31294483 DOI: 10.1002/jat.3838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Akai S, Oda S, Yokoi T. Strain and interindividual differences in lamotrigine-induced liver injury in mice. J Appl Toxicol 2019;39:451-60. [PMID: 30325050 DOI: 10.1002/jat.3736] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Yokoi T, Nakajima M. Toxicological implications of modulation of gene expression by microRNAs. Toxicol Sci 2011;123:1-14. [PMID: 21715665 DOI: 10.1093/toxsci/kfr168] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
15 Kumar N, Surani S, Udeani G, Mathew S, John S, Sajan S, Mishra J. Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies. Life Sci 2021;278:119544. [PMID: 33945827 DOI: 10.1016/j.lfs.2021.119544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Njoku DB. Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. Int J Mol Sci. 2014;15:6990-7003. [PMID: 24758937 DOI: 10.3390/ijms15046990] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
17 Xi L, Yao J, Wei Y, Wu X, Yao X, Liu H, Li S. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury. Mol Biosyst 2017;13:417-24. [PMID: 28092392 DOI: 10.1039/c6mb00744a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
18 Tu C, Niu M, Wei AW, Tang JF, Zhang L, Jing J, Xiao XH, Wang JB. Susceptibility-Related Cytokine Panel for Prediction of Polygonum multiflorum-Induced Hepatotoxicity in Humans. J Inflamm Res 2021;14:645-55. [PMID: 33692634 DOI: 10.2147/JIR.S299892] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kobayashi M, Higuchi S, Ide M, Nishikawa S, Fukami T, Nakajima M, Yokoi T. Th2 cytokine-mediated methimazole-induced acute liver injury in mice: Methimazole-induced hepatotoxicity. J Appl Toxicol 2012;32:823-33. [DOI: 10.1002/jat.2731] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
20 Matsubara A, Oda S, Jia R, Yokoi T. Acute kidney injury model established by systemic glutathione depletion in mice. J Appl Toxicol 2019;39:919-30. [DOI: 10.1002/jat.3780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Takai S, Higuchi S, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice: Flucloxacillin-induced liver injury. J Appl Toxicol 2015;35:142-51. [DOI: 10.1002/jat.3002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
22 Tajiri K, Shimizu Y. Immunological aspects of drug-induced liver injury. World J Immunol 2014; 4(3): 149-157 [DOI: 10.5411/wji.v4.i3.149] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Higuchi S, Kobayashi M, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury. J Appl Toxicol 2012;32:815-22. [PMID: 21735453 DOI: 10.1002/jat.1706] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
24 Steuerwald NM, Foureau DM, Norton HJ, Zhou J, Parsons JC, Chalasani N, Fontana RJ, Watkins PB, Lee WM, Reddy KR. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One. 2013;e81974. [PMID: 24386086 DOI: 10.1371/journal.pone.0081974] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
25 Saito K, Uebanso T, Maekawa K, Ishikawa M, Taguchi R, Nammo T, Nishimaki-Mogami T, Udagawa H, Fujii M, Shibazaki Y, Yoneyama H, Yasuda K, Saito Y. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. Sci Rep 2015;5:12466. [PMID: 26289793 DOI: 10.1038/srep12466] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
26 Sykes L, Herbert BR, Macintyre DA, Hunte E, Ponnampalam S, Johnson MR, Teoh TG, Bennett PR. The CRTH2 agonist Pyl A prevents lipopolysaccharide-induced fetal death but induces preterm labour. Immunology 2013;139:352-65. [PMID: 23374103 DOI: 10.1111/imm.12085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]